These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15895462)

  • 1. The phenotypic spectrum of COL2A1 mutations.
    Nishimura G; Haga N; Kitoh H; Tanaka Y; Sonoda T; Kitamura M; Shirahama S; Itoh T; Nakashima E; Ohashi H; Ikegawa S
    Hum Mutat; 2005 Jul; 26(1):36-43. PubMed ID: 15895462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of exon 12 of the COL2A1 gene interrupts the triple helix of type-II collagen in the Kniest form of spondyloepiphyseal dysplasia.
    Chen L; Yang W; Cole WG
    J Orthop Res; 1996 Sep; 14(5):712-21. PubMed ID: 8893763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene.
    Hoornaert KP; Dewinter C; Vereecke I; Beemer FA; Courtens W; Fryer A; Fryssira H; Lees M; Müllner-Eidenböck A; Rimoin DL; Siderius L; Superti-Furga A; Temple K; Willems PJ; Zankl A; Zweier C; De Paepe A; Coucke P; Mortier GR
    J Med Genet; 2006 May; 43(5):406-13. PubMed ID: 16155195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficiency of mutation detection in type 1 stickler syndrome using a two-stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1.
    Richards AJ; Laidlaw M; Whittaker J; Treacy B; Rai H; Bearcroft P; Baguley DM; Poulson A; Ang A; Scott JD; Snead MP
    Hum Mutat; 2006 Jul; 27(7):696-704. PubMed ID: 16752401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent c.G1636A (p.G546S) mutation of COL2A1 in a Chinese family with skeletal dysplasia and different metaphyseal changes: a case report.
    Chen J; Ma X; Zhou Y; Li G; Guo Q
    BMC Pediatr; 2017 Jul; 17(1):175. PubMed ID: 28738883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation and COL2A1 gene analysis in 21 Brazilian families with Stickler syndrome: identification of novel mutations, further genotype/phenotype correlation, and its implications for the diagnosis.
    Zechi-Ceide RM; Jesus Oliveira NA; Guion-Almeida ML; Antunes LF; Richieri-Costa A; Passos-Bueno MR
    Eur J Med Genet; 2008; 51(3):183-96. PubMed ID: 18276201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense and nonsense mutations in the alternatively-spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome.
    McAlinden A; Majava M; Bishop PN; Perveen R; Black GC; Pierpont ME; Ala-Kokko L; Männikkö M
    Hum Mutat; 2008 Jan; 29(1):83-90. PubMed ID: 17721977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect.
    Winterpacht A; Hilbert M; Schwarze U; Mundlos S; Spranger J; Zabel BU
    Nat Genet; 1993 Apr; 3(4):323-6. PubMed ID: 7981752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.
    Zankl A; Neumann L; Ignatius J; Nikkels P; Schrander-Stumpel C; Mortier G; Omran H; Wright M; Hilbert K; Bonafé L; Spranger J; Zabel B; Superti-Furga A
    Am J Med Genet A; 2005 Feb; 133A(1):61-7. PubMed ID: 15643621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1.
    Richards AJ; McNinch A; Martin H; Oakhill K; Rai H; Waller S; Treacy B; Whittaker J; Meredith S; Poulson A; Snead MP
    Hum Mutat; 2010 Jun; 31(6):E1461-71. PubMed ID: 20513134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation of COL2A1 resulting in dominantly inherited rhegmatogenous retinal detachment.
    Richards AJ; Meredith S; Poulson A; Bearcroft P; Crossland G; Baguley DM; Scott JD; Snead MP
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):663-8. PubMed ID: 15671297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.
    Barat-Houari M; Sarrabay G; Gatinois V; Fabre A; Dumont B; Genevieve D; Touitou I
    Hum Mutat; 2016 Jan; 37(1):7-15. PubMed ID: 26443184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for Stickler's syndrome: ocular phenotype of mice carrying a targeted heterozygous inactivation of type II (pro)collagen gene (Col2a1).
    Kaarniranta K; Ihanamäki T; Sahlman J; Pulkkinen H; Uusitalo H; Arita M; Tammi R; Lammi MJ; Helminen HJ
    Exp Eye Res; 2006 Aug; 83(2):297-303. PubMed ID: 16546167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location and type of mutation in the LIS1 gene do not predict phenotypic severity.
    Uyanik G; Morris-Rosendahl DJ; Stiegler J; Klapecki J; Gross C; Berman Y; Martin P; Dey L; Spranger S; Korenke GC; Schreyer I; Hertzberg C; Neumann TE; Burkart P; Spaich C; Meng M; Holthausen H; Adès L; Seidel J; Mangold E; Buyse G; Meinecke P; Schara U; Zeschnigk C; Muller D; Helland G; Schulze B; Wright ML; Kortge-Jung S; Hehr A; Bogdahn U; Schuierer G; Kohlhase J; Aigner L; Wolff G; Hehr U; Winkler J
    Neurology; 2007 Jul; 69(5):442-7. PubMed ID: 17664403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant spondylarthropathy due to a type II procollagen gene (COL2A1) point mutation.
    Winterpacht A; Hilbert M; Schwarze U; Mundlos S; Spranger J; Zabel B
    Hum Mutat; 1994; 4(4):257-62. PubMed ID: 7866404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding spectrum of COL2A1 gene variants IN 136 patients with a skeletal dysplasia phenotype.
    Barat-Houari M; Dumont B; Fabre A; Them FT; Alembik Y; Alessandri JL; Amiel J; Audebert S; Baumann-Morel C; Blanchet P; Bieth E; Brechard M; Busa T; Calvas P; Capri Y; Cartault F; Chassaing N; Ciorca V; Coubes C; David A; Delezoide AL; Dupin-Deguine D; El Chehadeh S; Faivre L; Giuliano F; Goldenberg A; Isidor B; Jacquemont ML; Julia S; Kaplan J; Lacombe D; Lebrun M; Marlin S; Martin-Coignard D; Martinovic J; Masurel A; Melki J; Mozelle-Nivoix M; Nguyen K; Odent S; Philip N; Pinson L; Plessis G; Quélin C; Shaeffer E; Sigaudy S; Thauvin C; Till M; Touraine R; Vigneron J; Baujat G; Cormier-Daire V; Le Merrer M; Geneviève D; Touitou I
    Eur J Hum Genet; 2016 Jul; 24(7):992-1000. PubMed ID: 26626311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of deletion of a COL2A1 allele as the mutation in Stickler syndrome shows that a collagen type II dosage effect underlies this syndrome.
    Van Der Hout AH; Verlind E; Beemer FA; Buys CH; Hofstra RM; Scheffer H
    Hum Mutat; 2002 Sep; 20(3):236. PubMed ID: 12204008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stickler and branchio-oto-renal syndromes in a patient with mutations in EYA1 and COL2A1 genes.
    Olavarrieta L; Morales-Angulo C; del Castillo I; Moreno F; Moreno-Pelayo MA
    Clin Genet; 2008 Mar; 73(3):262-7. PubMed ID: 18177466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Heterozygous Mutation in the Triple Helical Region of the Alpha 1 (II) Chain of the COL2A1 Protein Causes Non-Lethal Spondyloepiphyseal Dysplasia Congenita.
    Almatrafi A; Alfadhli F; Khan YN; Afzal S; Hashmi JA; Ullah A; Albalawi AM; Basit S
    Genet Test Mol Biomarkers; 2019 May; 23(5):310-315. PubMed ID: 30932712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.